Carroll Financial Associates’s Jazz Pharmaceuticals JAZZ Stock Holding History

Carroll Financial Associates’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$4K	Sell	33 -1	-3%	-$131	﹤0.01%	1383
2021 Q3	$4K	Sell	34 -374	-92%	-$56.5K	﹤0.01%	1422
2021 Q2	$72K	Buy	408 +397	+3,609%	+$68.8K	﹤0.01%	683
2021 Q1	$1K	Hold	11	–	–	﹤0.01%	1574
2020 Q4	$1K	Hold	11	–	–	﹤0.01%	1466
2020 Q3	$1K	Hold	11	–	–	﹤0.01%	1422
2020 Q2	$1K	Hold	11	–	–	﹤0.01%	1437
2020 Q1	$1K	Sell	11 -75	-87%	-$9.7K	﹤0.01%	1373
2019 Q4	$12K	Hold	86	–	–	﹤0.01%	998
2019 Q3	$11K	Sell	86 -120	-58%	-$16.1K	﹤0.01%	968
2019 Q2	$29K	Buy	206 +6	+3%	+$806	﹤0.01%	724
2019 Q1	$28K	Buy	200 +125	+167%	+$16.3K	﹤0.01%	673
2018 Q4	$9K	Buy	+75	New	+$11.1K	﹤0.01%	888
2018 Q1	–	Sell	-11	Closed	-$1K	–	1288
2017 Q4	$1K	Buy	+11	New	+$1.53K	﹤0.01%	1177
2016 Q1	–	Sell	-100	Closed	-$14K	–	1165
2015 Q4	$14K	Hold	100	–	–	﹤0.01%	667
2015 Q3	$12K	Hold	100	–	–	﹤0.01%	679
2015 Q2	$18K	Hold	100	–	–	﹤0.01%	584
2015 Q1	$17K	Hold	100	–	–	0.01%	446
2014 Q4	$17K	Sell	100 -60	-38%	-$9.96K	0.01%	411
2014 Q3	$27K	Hold	160	–	–	0.01%	406
2014 Q2	$24K	Hold	160	–	–	0.01%	442
2014 Q1	$22K	Hold	160	–	–	0.01%	408
2013 Q4	$20K	Hold	160	–	–	0.01%	414
2013 Q3	$14K	Hold	160	–	–	0.01%	476
2013 Q2	$10K	Buy	+160	New	+$9.78K	﹤0.01%	407

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Carroll Financial Associates's JAZZ Position: Q4 2021 in Review

Carroll Financial Associates reduced its Jazz Pharmaceuticals (JAZZ) stake by 2.9% in Q4 2021, selling an estimated $131 and leaving 33 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #1383.

Carroll Financial Associates first reported a position in JAZZ in Q2 2013 and has held it in 25 quarters since. The position peaked at $72K in Q2 2021. 454 funds tracked by Wall St. Rank hold JAZZ as of Q4 2021.

Carroll Financial Associates held 33 shares of Jazz Pharmaceuticals worth $4K as of Q4 2021.
Carroll Financial Associates sold 1 Jazz Pharmaceuticals share in Q4 2021, an estimated $131.
Jazz Pharmaceuticals made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #1383 holding.
Carroll Financial Associates first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 25 quarters since.
Carroll Financial Associates's Jazz Pharmaceuticals position peaked at $72K in Q2 2021.
454 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.